Form 4 for NSPR InspireMD, Inc.
Accepted 2024-01-25 00:00:00 ET · period of report 2024-01-23 · accession 0001493152-24-003777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-25 | 2024-01-23 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +238.6K | 514.4K | +87% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Gleason Shane Thomas | Chief Commercial Off | A - Grant | $0.00 | +91.2K | 183.1K | +99% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-23 | A | A | 238,625 | $0.00 | 514,365 | D | — | — | (F1) These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2024-01-23 | A | A | 91,218 | $0.00 | 183,128 | D | $3.14 · — to 2034-01-23 | 91,218 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. |